Cargo Insurance Certificate Requirements for Pharmaceutical LCs and NPRA Import Transactions

The cargo insurance certificate is one of the most consequential documents in a Letter of Credit-funded pharmaceutical import. It is the document that the importer's bank checks against the LC terms before releasing payment to the overseas principal. It is the document that the importer's quality and risk team relies on to confirm coverage is in place for the temperature-sensitive cargo at risk. It is also the document that catches the largest number of LC discrepancies in pharmaceutical transactions, because pharmaceutical certificates have to satisfy two frameworks at the same time: the standard UCP 600 Article 28 banking compliance requirements, and the pharmaceutical-specific endorsement and documentation expectations that an NPRA-licensed importer carries.

This guide walks through what a pharmaceutical cargo insurance certificate must contain to satisfy both frameworks, the common discrepancy patterns that delay LC negotiation, and the placement-time fix that produces a certificate the bank's checking team and the importer's quality team can both rely on. The primary references are UCP 600 Article 28 (International Chamber of Commerce, 2007 edition still current as of May 2026), the Voyage LC Insurance Certificate Requirements guide for the wider framework, and the NPRA Guideline on Application of Manufacturer's, Import and Wholesaler's Licenses for Registered Products (3rd Edition, March 2025) for the import licence conditions.

Key Facts: Cargo Insurance Certificate Requirements for Pharmaceutical LCs

What is UCP 600 Article 28? The Uniform Customs and Practice for Documentary Credits, 2007 Revision, ICC Publication 600, is the global banking standard for documentary credits. Article 28 sets the requirements for insurance documents presented under a Letter of Credit, covering issuer eligibility, signature, dating, currency, value, and clause matching.

What insured value does UCP 600 Article 28 require? At minimum, CIF or CIP value plus 10 percent uplift, unless the LC specifies otherwise. The currency of the insurance document must be the same as the LC currency. The document must be dated no later than the shipment date, or it must indicate that cover attached no later than the shipment date.

What additional requirements do pharmaceutical LC certificates have? Pharmaceutical certificates must reference the specific endorsements the cargo policy actually carries: temperature deviation cover, reefer equipment breakdown extension for sea reefer, Montreal Convention gap cover for air freight, controlled substances handling where Schedule 1 or Schedule 2 poisons are involved, and any GDP-aligned documentation clauses. A bare Institute Cargo Clauses (A) reference is rarely sufficient for the importer's actual risk position, even where it satisfies the bank.

What is the typical LC discrepancy pattern on pharmaceutical certificates? Mismatched currency between certificate and LC; certificate dated after the bill of lading or airway bill date; insured value at CIF or CIP value only without the 10 percent uplift; certificate issued by an entity that is not an insurer, underwriter, or their authorised agent; coverage scope that does not match the LC's stated requirements. Each of these triggers a discrepancy that delays bank acceptance.

How does the NPRA Import Licence interact with the LC certificate? The NPRA Import Licence holder is the named insured on the certificate, with the insurable interest matching the licence holder's commercial position from the Incoterms 2020 risk transfer point onwards. Certificates issued in the overseas supplier's name without the importer as the assured (or as a co-assured) create a gap at the Malaysian end of the transaction.

For the foundational explainer on LC certificate compliance generally, see the LC Insurance Certificate Requirements guide. For the pharmaceutical cluster context, see the pharmaceutical imports cargo insurance cluster hub and the Pharmaceutical & Medical Devices Cargo Insurance industry page.

Resource: Cargo Insurance Coverage Audit

Take the 9-question Cargo Insurance Coverage Audit to score your pharmaceutical cargo cover and LC certificate workflow against the UCP 600 Article 28 baseline. Free, no signup wall.

What UCP 600 Article 28 Actually Requires

UCP 600 Article 28 sets out the bank's checking requirements for insurance documents presented under a Letter of Credit. The article's effect is operational rather than substantive: it determines whether the bank will accept the document as compliant with the LC, not whether the underlying insurance is good cover. The two checks are different, and the pharmaceutical importer needs to pass both.

The six requirements above are mechanical and easy to miss in any one of them. Bank checking departments are trained on UCP 600 Article 28 specifically, so they catch discrepancies even where the underlying cover is good. The remedy is procedural: get the certificate right at issue.

What Pharmaceutical-Specific Certificates Need Beyond UCP 600

UCP 600 Article 28 is necessary but not sufficient for pharmaceutical cargo. An NPRA-licensed importer reviewing a certificate against their actual risk position needs to confirm that the certificate reflects the pharmaceutical-specific endorsements the cargo policy carries.

The Common Discrepancy Patterns

Five discrepancy patterns recur in pharmaceutical LC certificate negotiation.

Currency mismatch. A USD LC paired with an insurance certificate denominated in EUR or MYR. The fix is to align the certificate currency to the LC at the time of issue, not after.

Insured value short of CIF or CIP plus 10 percent. Certificate issued at invoice value alone, or at CIF without the uplift. The fix is to instruct the placement broker to issue the certificate at the correct UCP 600 minimum (or higher where the LC specifies).

Certificate dated after the bill of lading or airway bill. The certificate must be dated no later than the shipment date evidenced by the transport document, or it must include language stating that cover attached on or before that date. A certificate issued days after dispatch with no back-dating language is a discrepancy.

Clauses not matching the LC. Where the LC specifies "Institute Cargo Clauses (A) 1.1.2009" and the certificate evidences a different clause set or year, the discrepancy is clear. For pharmaceutical LCs that specify ICC (A) and additional endorsements, every named endorsement should appear on the certificate.

Assured not the importer. Certificates issued in the overseas supplier's name only, without the Malaysian NPRA Import Licence holder as the assured or as co-assured, create both an LC discrepancy and a recovery gap at the Malaysian end of the transaction. The fix is to specify the assured naming in the LC and confirm at certificate issue.

How the NPRA Import Licence Interacts with the LC Certificate

For pharmaceutical imports into Malaysia, the LC certificate sits alongside the NPRA Import Licence in the importer's compliance file. The two documents are not formally linked by NPRA regulation, but they overlap operationally in three ways.

Insurable interest alignment. The NPRA Import Licence holder is the party with insurable interest on the cargo from the Incoterms 2020 risk transfer point onwards. For the importer's specific licence framework, see the cluster article on NPRA Import Licence requirements. The LC certificate should name the licence holder as the assured, so the policy and the licence point at the same party. See the related cluster article on temperature excursion liability for the underlying insurable interest framework.

Customs clearance documentation. Royal Malaysian Customs (JKDM) reviews the cargo insurance certificate as part of the import documentation pack at clearance. While JKDM's primary focus is the customs value and duty calculation, the certificate's date and scope are confirmed at this stage. A certificate that is materially out of date or that does not cover the actual shipment route may trigger questions at clearance.

Bonded warehouse and Customs warehouse considerations. Where pharmaceutical cargo dwells at a bonded warehouse or in a Customs warehouse during clearance, the cargo insurance certificate should cover the dwell period explicitly. The standard warehouse-to-warehouse transit clause at ICC (A) 2009 Clause 8 has specific termination triggers; the placement should confirm the cover extends through the realistic clearance window.

The Placement-Time Fix: Standardising the Pharmaceutical Certificate

The protective practice for pharmaceutical importers running LC-funded import programmes is to standardise the certificate at placement, before the first LC under the open cover ships.

Step 1: Agree the certificate template. The broker, insurer, and importer agree a certificate template specific to pharmaceutical cargo, with the named endorsements written into the body of the certificate rather than left to be inferred from the underlying policy wording. The template includes UCP 600 Article 28 compliance elements and the pharmaceutical-specific endorsements.

Step 2: Map the LC structures. The importer maps the typical LC structures used in their pharmaceutical purchasing programme: the issuing bank, the typical Incoterm, the typical currency, the typical shipment-to-presentation timing, and any standing instructions on insurance clauses. The certificate template is then validated against the typical LC pattern.

Step 3: Pre-issue review on the first few LCs. The first few certificates issued under the standardised template are reviewed by the importer's bank's checking team (informally, as a pre-presentation review where the bank accepts this) before formal presentation. Any discrepancies are corrected at template level, not at individual certificate level.

Step 4: Operationalise. Once the template is validated, the broker issues certificates on the standardised template for every LC-funded pharmaceutical shipment. Discrepancies should reduce materially. The remaining residual discrepancies typically arise from changes in the LC terms (different Incoterm, different currency, different clauses), which are detectable upfront.

LC certificate discrepancies delay payment to your overseas principal. Standardise at placement, not at LC.

Voyage arranges open cover marine cargo insurance for NPRA-licensed pharmaceutical importers with standardised UCP 600 Article 28-compliant certificates and pharmaceutical-specific endorsements negotiated at placement. Request a coverage review at voyagecover.com/#contact-form or WhatsApp Kevin at +60 19 990 2450.

Pharmaceutical-Specific LC Wording: What to Look For

Pharmaceutical LCs commonly include insurance clauses beyond the standard UCP 600 Article 28 baseline. The most common variations are:

• Specified insurance clauses. "Insurance against all risks including war and strikes risks, by ICC (A) 1/1/2009, Institute War Clauses (Cargo) CL385 1/1/2009, Institute Strikes Clauses (Cargo) CL386 1/1/2009." The certificate must evidence each named clause.
• Specified excess uplift. Some LCs specify CIF or CIP value plus 15 or 20 percent, particularly for pharmaceutical cargo where the standard 10 percent UCP 600 minimum is treated as inadequate. The certificate must match the LC's specific uplift.
• Specified assured naming. "Insurance certificate to be issued in the name of [Importer Sdn Bhd] as Assured, or to order, blank endorsed." The certificate must follow the specified naming format.
• Specified warehouse coverage. "Cover from supplier's warehouse to importer's GDP-certified warehouse in Malaysia." The certificate's coverage scope must reflect this end-to-end transit.
• Temperature deviation reference. Some LCs specify that the cargo insurance must include temperature deviation cover for the cold chain product. The certificate must explicitly reference the temperature deviation endorsement.

For Malaysian pharmaceutical importers negotiating LC terms with overseas suppliers, the insurance section of the LC is one of the negotiation points worth using. Specifying the clauses, uplift, and assured naming at the LC stage avoids discrepancies later.

Air Freight LC Certificates and the Montreal Convention

For air freight pharmaceutical imports under LC, the certificate has one additional dimension: the Montreal Convention 1999 gap.

The Montreal Convention's 26 SDR per kilogramme carrier liability cap (effective 28 December 2024 under the ICAO five-year inflation review, approximately $35 per kilogramme at April 2026 rates) sits beneath the cargo insurance policy. The cargo insurance certificate should reflect that the policy responds for the gap between the convention cap and the cargo's commercial value. For high-value biologics under LC, the gap is the bulk of the cargo's value.

The certificate's insured value (CIF or CIP plus 10 percent uplift as the UCP 600 minimum, or the LC's specified higher uplift) is what the policy responds up to, less any deductibles and subject to per-shipment limits. The Montreal Convention gap cover should be referenced explicitly, so the bank, the importer, and any subsequent claim assessor know the gap is closed under the policy.

Reefer Sea Freight LC Certificates and Equipment Breakdown

For sea reefer pharmaceutical imports under LC, the equivalent additional dimension is the reefer equipment breakdown extension.

Standard Institute Cargo Clauses (A) 2009 covers physical loss or damage in transit, but mechanical or electrical failure of the refrigeration system typically falls outside the base wording without specific endorsement. The reefer equipment breakdown extension should be named on the certificate, so the bank and importer know the cargo's most material sea freight failure mode is covered.

For LC-funded pharmaceutical sea reefer programmes, the certificate should also reference the Hague-Visby Rules cap of SDR 666.67 per package or 2 SDR per kilogramme of gross weight (whichever is higher) implicitly by confirming the cargo insurance covers the gap between carrier liability and cargo value. For the underlying convention, see Hague-Visby Rules.

Frequently Asked Questions

What is UCP 600 Article 28 and why does it apply to pharmaceutical LCs?

UCP 600 Article 28 is the part of the Uniform Customs and Practice for Documentary Credits (ICC Publication 600, 2007 Revision) that sets the banking requirements for insurance documents under Letters of Credit. It applies to every LC governed by UCP 600, including pharmaceutical LCs into Malaysia. The article covers issuer eligibility, signature, dating, currency, value, and clause matching.

What is the minimum insured value under UCP 600 Article 28?

At minimum, CIF or CIP value plus 10 percent uplift, unless the LC specifies a different basis. The minimum applies even where the underlying purchase contract used a different Incoterm. For pharmaceutical biologics where the 10 percent uplift may be inadequate to cover replacement cost, the LC should specify a higher uplift (commonly 15 to 25 percent for biologics).

Can an overseas supplier's insurance certificate satisfy the Malaysian importer's risk position?

Only partially. A CIF certificate from the overseas supplier under UCP 600 Article 28 requires only ICC (C) minimum cover under Incoterms 2020, which is rarely fit for pharmaceutical cargo. A CIP certificate requires ICC (A) minimum (upgraded from (C) in the 2020 revision), which is the practical pharmaceutical baseline. Even where CIP is used, the importer typically needs top-up cover for the pharmaceutical-specific endorsements (temperature deviation, reefer equipment breakdown, Montreal gap, controlled substances, GDP documentation).

What is the difference between a certificate of insurance and a cover note?

A certificate of insurance is issued by the insurer or the insurer's authorised agent and provides evidence of cover under a defined policy. A cover note is typically issued by a broker or intermediary to confirm that cover has been arranged. Under UCP 600 Article 28, the document must be issued and signed by an insurer, underwriter, or their agent or proxy; a cover note from an intermediary without insurer authorisation is not acceptable. For pharmaceutical LCs, certificates of insurance are the standard.

How does the cargo insurance certificate work under an open cover?

Under an annual open cover marine cargo insurance facility, the importer makes monthly or per-shipment declarations to the broker or insurer. For each LC-funded shipment, a certificate of insurance is issued under the open cover, with the certificate referencing the policy and providing the specific insured value, route, and clauses for that consignment. The certificate is the document presented under the LC; the underlying policy provides the cover.

What happens if the LC certificate has a discrepancy?

The bank checking the documents will flag the discrepancy and either reject the documents or accept under reserve. Where rejected, payment is delayed pending correction. Where accepted under reserve, the buyer or beneficiary may face additional cost or commercial consequences depending on the LC terms. Discrepancies on insurance certificates are one of the most common LC issues, which is why standardising the certificate at placement is the protective practice.

How does the certificate reference temperature deviation cover?

The certificate should explicitly state the temperature deviation endorsement is in force, with reference to the temperature range and the excursion trigger as agreed at placement. A bare "Institute Cargo Clauses (A) 1.1.2009" reference does not satisfy the pharmaceutical-specific risk position, even where it satisfies the bank's UCP 600 Article 28 checks.

Does the certificate need to be signed or only stamped?

Under UCP 600 Article 28, the document must be signed by the insurer, underwriter, or their agent or proxy. A stamp without a signature can be acceptable where the stamp itself constitutes the authorised mark of issuance under the issuing entity's practice, but banks typically expect a signed certificate. The placement broker should confirm the issuance practice with the insurer at placement.

Voyage Conclusion

Pharmaceutical LC certificates have to satisfy two frameworks: UCP 600 Article 28 for banking compliance and the pharmaceutical-specific endorsement and assured-naming expectations for the importer's actual risk position. The two frameworks overlap but are not identical, and certificates that satisfy one without the other create either LC discrepancies (delaying payment to the overseas principal) or recovery gaps (leaving the NPRA-licensed importer exposed at claim). The protective practice is to standardise the certificate at placement against both frameworks, before the first LC under the open cover ships.

Voyage arranges open cover marine cargo insurance for NPRA-licensed pharmaceutical importers with standardised UCP 600 Article 28-compliant certificates and pharmaceutical-specific endorsements negotiated at placement. Request a quote at voyagecover.com/#contact-form or WhatsApp Kevin at +60 19 990 2450. For the wider cluster, see the pharmaceutical imports cargo insurance cluster hub, the Pharmaceutical & Medical Devices Cargo Insurance industry page, and the foundational LC Insurance Certificate Requirements guide.

Disclaimer: This article provides general guidance on cargo insurance certificate requirements for pharmaceutical Letters of Credit and NPRA import transactions as of May 2026. UCP 600 (2007 Revision) is the current ICC banking standard. Specific LC wording, bank checking practice, and pharmaceutical certificate templates vary; review specific certificates against your LC before presentation.

Coverage terms, conditions, and availability vary by insurer, policy, and jurisdiction. Always review your specific policy wording and consult a qualified insurance or legal professional before making coverage decisions.